The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
Abstract
Objective : Low levels of testosterone in men have been shown to be associated with type 2 diabetes, visceral adiposity, dyslipidaemia and metabolic syndrome. We investigated the effect of testosterone treatment on insulin resistance and glycaemic control in hypogonadal men with type 2 diabetes. Design : This was a double-blind placebo-controlled crossover study in 24 hypogonadal men (10 treated with insulin) over the age of 30 years with type 2 diabetes. Methods : Patients were treated with i.m. testosterone 200 mg every 2 weeks or placebo for 3 months in random order, followed by a washout period of 1 month before the alternate treatment phase. The primary outcomes were changes in fasting insulin sensitivity (as measured by homeostatic model index (HOMA) in those not on insulin), fasting blood glucose and glycated haemoglobin. The secondary outcomes were changes in body composition, fasting lipids and blood pressure. Statistical analysis was performed on the delta values, with the treatment effect of placebo compared against the treatment effect of testosterone. Results : Testosterone therapy reduced the HOMA index (−1.73 ± 0.67, P = 0.02, n = 14), indicating an improved fasting insulin sensitivity. Glycated haemoglobin was also reduced (−0.37 ± 0.17%, P = 0.03), as was the fasting blood glucose (−1.58 ± 0.68 mmol/l, P = 0.03). Testosterone treatment resulted in a reduction in visceral adiposity as assessed by waist circumference (−1.63 ± 0.71 cm, P = 0.03) and waist/hip ratio (−0.03 ± 0.01, P = 0.01). Total cholesterol decreased with testosterone therapy (−0.4 ± 0.17 mmol/l, P = 0.03) but no effect on blood pressure was observed. Conclusions : Testosterone replacement therapy reduces insulin resistance and improves glycaemic control in hypogonadal men with type 2 diabetes. Improvements in glycaemic control, insulin resistance, cholesterol and visceral adiposity together represent an overall reduction in cardiovascular risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Insulin sensitivity may improve within few days, but effects on glycemic control become evident only after 3–12 months.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“and a decrease in the waist hip ratio after 3 months (31, 36) or after 6 months and 30 weeks respectively (17).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“A decrease in trunk fat or waist circumference was noted in a number of studies after 3 months (35, 36) with continuous decline over 24 months (32)”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“Several studies indicate that upon testosterone administration, serum glucose is reduced after 3 months in men with impaired glucose tolerance (31, 36, 43).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“A decline in HbA1c was observed after 3 months (31, 36, 43) with further decrease after 12 months (43).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“A decrease in serum proinsulin and insulin was noted after 3 months (43) or 6 months (45), and a decrease in homeostasis model assessment index of insulin resistance (HOMA-IR) after 3 months (36) or 6 months (45–47).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“Certainly, testosterone replacement can improve performance, mood, and libido in men with hypogonadism (22) and augments insulin sensitivity (11,15).”
From Low testosterone levels are common and associated with insulin resistance in men with diabetes (2008) · cites this paper as [11]
In the citing paper
“T plays an important role in maintaining glycemic control [2].”
In the citing paper
“Furthermore, there is recent evidence that testosterone replacement therapy improves insulin resistance, glycemic control, cholesterol levels, and waist circumference in diabetic men with low testosterone levels (26).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [26]
In the citing paper
“Testosterone treatment has also been shown to reduce insulin resistance in obese men (23,24), men with heart failure (25), and type 2 diabetic subjects (26).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [26]
In the citing paper
“Two studies in type 2 diabetic men have shown an improvement in glycemic control (26,27) with testosterone replacement therapy”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [26]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731
Self-citationThe assessment of insulin resistance in man
Wallace, T. M., & Matthews, D. R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00745.x · Cited by 685
Validation of a screening questionnaire for androgen deficiency in aging males
Morley, J. E., Charlton, E., Patrick, P., Kaiser, F. E., Cadeau, P., McCready, D., & Perry, H. M. (2000) · Metabolism · doi:10.1053/meta.2000.8625 · Cited by 662
(1996) · PubMed · Cited by 643
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0804 · Cited by 631
Stellato, R. K., Feldman, H. A., Hamdy, O., Horton, E. S., & McKinlay, J. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.490 · Cited by 618
Oh, J.-Y., Barrett-Connor, E., Wedick, N. M., & Wingard, D. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.55 · Cited by 594
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 785
A comprehensive diagnostic approach to detect underlying causes of obesity in adults
van der Valk, E. S., van den Akker, E. L. T., Savas, M., Kleinendorst, L., Visser, J. A., van Haelst, M. M., Sharma, A. M., & van Rossum, E. F. C. (2019) · Obesity Reviews · doi:10.1111/obr.12836 · Cited by 138
Saad, F., Yassin, A., Doros, G., & Haider, A. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.139 · Cited by 131
Obesity, low testosterone levels and erectile dysfunction
Diaz‐Arjonilla, M., Schwarcz, M. G., Swerdloff, R. S., & Wang, C. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.42 · Cited by 134
Traish, A. M., Haider, A., Haider, K. S., Doros, G., & Saad, F. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417691136 · Cited by 130
Yeap, B. B., Chubb, S. A. P., Hyde, Z., Jamrozik, K., Hankey, G. J., Flicker, L., & Norman, P. E. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0348 · Cited by 128
Testosterone for the aging male; current evidence and recommended practice
Jones, H. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s190 · Cited by 204
Yeap, B. B., Almeida, O. P., Hyde, Z., Norman, P. E., Chubb, S. A. P., Jamrozik, K. D., & Flicker, L. A. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0714 · Cited by 126
van Velzen, D. M., Paldino, A., Klaver, M., Nota, N. M., Defreyne, J., Hovingh, G. K., Thijs, A., Şimşek, S., T'Sjoen, G. G., & den Heijer, M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02138 · Cited by 124
Corona, G., Mannucci, E., Ricca, V., Lotti, F., Boddi, V., Bandini, E., Balercia, G., Forti, G., & Maggi, M. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00952.x · Cited by 121
McInnes, K. J., Smith, L. B., Hunger, N. I., Saunders, P. T. K., Andrew, R., & Walker, B. R. (2012) · Diabetes · doi:10.2337/db11-1136 · Cited by 124
Nettleship, J. E., Jones, T. H., Channer, K. S., & Jones, R. D. (2007) · Circulation · doi:10.1161/circulationaha.107.708768 · Cited by 119
Self-citationIsidori, A. M., Balercia, G., Calogero, A. E., Corona, G., Ferlin, A., Francavilla, S., Santi, D., & Maggi, M. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0155-9 · Cited by 118
Groti, K., Žuran, I., Antonič, B., Foršnarič, L., & Pfeifer, M. (2018) · The Aging Male · doi:10.1080/13685538.2018.1468429 · Cited by 117
Barron, A. M., Rosario, E. R., Elteriefi, R., & Pike, C. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078554 · Cited by 117
Testosterone in Obesity, Metabolic Syndrome and Type 2 Diabetes
Stanworth, R. D., & Jones, T. H. (2008) · Frontiers of hormone research · doi:10.1159/000176046 · Cited by 117
Self-citationThe Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials
Mohler, E. R., Ellenberg, S. S., Lewis, C. E., Wenger, N. K., Budoff, M. J., Lewis, M. R., Barrett-Connor, E. L., Swerdloff, R. S., Stephens‐Shields, A. J., Bhasin, S., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02243 · Cited by 116
Corona, G., Mannucci, E., Petrone, L., Balercia, G., Paggi, F., Fisher, A. D., Lotti, F., Chiarini, V., Fedele, D., Forti, G., et al. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00529.x · Cited by 116
Wang, K., Cai, X., Tian, Y., Wu, T., Cao, C., & Li, H. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122346 · Cited by 113
Why Is Androgen Replacement in Males Controversial?
Cunningham, G. R., & Toma, S. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0266 · Cited by 111
Goodale, T., Sadhu, A., Petak, S. M., & Robbins, R. J. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-2-68 · Cited by 114
Traish, A. M., Feeley, R. J., & Guay, A. T. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07305.x · Cited by 115
Hypothesis: Kisspeptin Mediates Male Hypogonadism in Obesity and Type 2 Diabetes
George, J. T., Millar, R. P., & Anderson, R. A. (2010) · Neuroendocrinology · doi:10.1159/000299767 · Cited by 110
Effects of Elevated β-Estradiol Levels on the Functional Morphology of the Testis - New Insights
Leavy, M., Trottmann, M., Liedl, B., Reese, S., Stief, C. G., Freitag, B., Baugh, J. A., Spagnoli, G. C., & Kölle, S. (2017) · Scientific Reports · doi:10.1038/srep39931 · Cited by 110
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170009 · Cited by 113
Giagulli, V. A., Carbone, M. D., Ramunni, M. I., Licchelli, B., De Pergola, G., Sabbà, C., Guastamacchia, E., & Triggiani, V. (2015) · Andrology · doi:10.1111/andr.12099 · Cited by 109
Chubb, S. A. P., Hyde, Z., Almeida, O. P., Flicker, L. A., Norman, P. E., Jamrozik, K. D., Hankey, G. J., & Yeap, B. B. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0893 · Cited by 109
Testosterone and type 2 diabetes
Grossmann, M., Gianatti, E. J., & Zajac, J. D. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833919cf · Cited by 108
Wu, K., Liang, T., Duan, X., Xu, L., Zhang, K., & Li, R. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.077 · Cited by 107
Corona, G., Forti, G., & Maggi, M. (2008) · The Aging Male · doi:10.1080/13685530802468497 · Cited by 107
Behre, H. M., Tammela, T. L. J., Arver, S., Tolrà, J. R., Bonifacio, V., Lamche, M., Kelly, J., Hiemeyer, F. J., for the European Testogel® Study Team, Giltay, E. J., et al. (2012) · The Aging Male · doi:10.3109/13685538.2012.699562 · Cited by 107
The role of hypogonadism in Klinefelter Syndrome
Bojesen, A., Høst, C., Skakkebaek, A. H., & Groth, K. A. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122201 · Cited by 109
The triad of erectile dysfunction, hypogonadism and the metabolic syndrome
Shabsigh, R., Arver, S., Channer, K. S., Ian Eardley, C., Fabbri, A., Gooren, L. J., Heufelder, A. E., Jones, H., Meryn, S., & Zitzmann, M. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01696.x · Cited by 105
Self-citationHaider, A., Yassin, A. A., Doros, G. D., & Saad, F. (2014) · International Journal of Endocrinology · doi:10.1155/2014/683515 · Cited by 101
Testosterone and glucose metabolism in men: current concepts and controversies
Grossmann, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0393 · Cited by 104
Usui, T., Kajita, K., Kajita, T., Mori, I., Hanamoto, T., Ikeda, T., Okada, H., Taguchi, K., Kitada, Y., Morita, H., et al. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.051 · Cited by 100
Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis
Yao, Q., Wang, B., An, X., Zhang, J., & Ding, L. (2017) · Endocrine Connections · doi:10.1530/ec-17-0253 · Cited by 100
Metabolic sequelae associated with androgen deprivation therapy for prostate cancer
Faris, J. E., & Smith, M. R. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283391fd1 · Cited by 99
Kelly, D. M., Nettleship, J. E., Akhtar, S., Muraleedharan, V., Sellers, D. J., Brooke, J. C., McLaren, D. S., Channer, K. S., & Jones, T. H. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.06.007 · Cited by 98
Self-citationSingh, P. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.123552 · Cited by 98
Greenfield, D., Walters, S. J., Coleman, R. E., Hancock, B. W., Eastell, R., Davies, H. A., Snowden, J. A., Derogatis, L. R., Shalet, S. M., & Ross, R. J. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2744 · Cited by 98
Treatment of Men for “Low Testosterone”: A Systematic Review
Huo, S., Scialli, A. R., McGarvey, S., Hill, E., Tügertimur, B., Hogenmiller, A., Hirsch, A. I., & Fugh-Berman, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162480 · Cited by 97
Corona, G., Mannucci, E., Forti, G., & Maggi, M. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00965.x · Cited by 96
Testosterone replacement therapy: for whom, when and how?
Tsametis, C. P., & Isidori, A. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.007 · Cited by 96
Hackett, G. I., Cole, N., Bhartia, M., Kennedy, D., Raju, J., Wilkinson, P., Saghir, A., & BLAST STUDY GROUP (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12235 · Cited by 95
Traish, A. M. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000086 · Cited by 95
Ren, X., Yin, R., Hou, D., Xue, Y., Zhang, M., Diao, X., Zhang, Y., Wu, J., Hu, J., Hu, X., et al. (2018) · Nutrients · doi:10.3390/nu10101509 · Cited by 96
Review: Testosterone and the metabolic syndrome
Muraleedharan, V., & Jones, T. H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810390258 · Cited by 98
Self-citationTestosterone therapy decreases subcutaneous fat and adiponectin in aging men
Frederiksen, L., Højlund, K., Hougaard, D. M., Mosbech, T. H., Larsen, R., Flyvbjerg, A., Frystyk, J., Brixen, K., & Andersen, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0565 · Cited by 93
Willemse, P.-P. M., Burggraaf, J., Hamdy, N. A. T., Weijl, N. I., VOSSEN, C. Y., van Wulften, L., Tol, A. Q. M. J. V. S.-V., Rosendaal, F. R., & Osanto, S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.226 · Cited by 93
Kelly, D. M., Akhtar, S., Sellers, D., Muraleedharan, V., Channer, K. S., & Jones, T. H. (2016) · Endocrine · doi:10.1007/s12020-016-1019-1 · Cited by 96
Self-citationJosiak, K., Jankowska, E. A., Piepoli, M. F., Banasiak, W., & Ponikowski, P. P. (2014) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-014-0152-z · Cited by 93
Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation
Annaloro, C., Usardi, P., Airaghi, L., Giunta, V., Forti, S., Orsatti, A., Baldini, M., Volpe, A. D., & Deliliers, G. L. (2008) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705972 · Cited by 91
Aversa, A., Bruzziches, R., Francomano, D., Spera, G., & Lenzi, A. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03350341 · Cited by 92
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
Jones, T. H. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00085.x · Cited by 91
Self-citationThe many faces of testosterone
Bain, J. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1417 · Cited by 90
Kapoor, D., Clarke, S., Channer, K. S., & Jones, T. H. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00744.x · Cited by 90
Self-citationDiagnosis and treatment of hypogonadism in men
Bhasin, S., & Basaria, S. S. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.12.002 · Cited by 89
Gender Differences in Lipid Metabolism and the Effect of Obesity
Magkos, F., & Mittendorfer, B. (2009) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2009.03.001 · Cited by 89
Stanworth, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2009) · Diabetes Care · doi:10.2337/dc08-1183 · Cited by 88
Self-citationTestosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment
Gianatti, E., & Grossmann, M. (2019) · Diabetic Medicine · doi:10.1111/dme.13977 · Cited by 86
Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review
Dandona, P., Dhindsa, S., Ghanim, H., & Saad, F. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14206 · Cited by 90
Testosterone and Coronary Artery Disease
Nettleship, J. E., Jones, R. D., Channer, K. S., & Jones, T. H. (2008) · Frontiers of hormone research · doi:10.1159/000176047 · Cited by 90
Self-citationTestosterone and cardiovascular disease in men
Morris, P., & Channer, K. S. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.21 · Cited by 86
Self-citationAndrogens and cardiovascular disease
Yeap, B. B. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283383031 · Cited by 87
The Metabolic Syndrome, a Human Disease
Alemany, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042251 · Cited by 86
SERMs: Progress and future perspectives
Pickar, J. H., MacNeil, T., & Ohleth, K. M. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.05.009 · Cited by 85
Sexual dysfunction in men with type 2 diabetes
Isidro, M. L. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-130069 · Cited by 86
A Comprehensive Review of Metabolic Syndrome Affecting Erectile Dysfunction
Kaya‐Sezginer, E., Sikka, S. C., & Gür, S. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12828 · Cited by 84
Human androgen deficiency: insights gained from androgen receptor knockout mouse models
Zajac, J. D., Rana, K., & Davey, R. A. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122590 · Cited by 91
Testosterone and the aging male: To treat or not to treat?
Bain, J. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.009 · Cited by 84
Stanworth, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0266 · Cited by 84
Self-citationBertram, S., Brixius, K., & Brinkmann, C. K. (2016) · Endocrine · doi:10.1007/s12020-016-0976-8 · Cited by 89
The prevalence of and risk factors for androgen deficiency in aging Taiwanese men
Liu, C.-C., Wu, W.-J., Lee, Y.-C., Wang, C.-J., Ke, H.-L., Li, W.-M., Hsiao, H.-L., Yeh, H.-C., Li, C.-C., Chou, Y.-H., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01171.x · Cited by 82
Haider, K. S., Haider, A., Saad, F., Doros, G., Hanefeld, M., Dhindsa, S., Dandona, P., & Traish, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14122 · Cited by 82
Guay, A. T., & Jacobson, J. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00530.x · Cited by 82
Shadid, S., Abosi-Appeadu, K., Maertelaere, A.-S. D., Defreyne, J., Veldeman, L., Holst, J. J., Lapauw, B., Vilsbøll, T., & T'Sjoen, G. G. (2019) · Diabetes Care · doi:10.2337/dc19-1061 · Cited by 87
Cornoldi, A., Caminiti, G., Marazzi, G., Vitale, C., Patrizi, R., Volterrani, M., Miceli, M., Fini, M., Spera, G., & Rosano, G. M. C. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.12.107 · Cited by 81
Rana, K., Fam, B. C., Clarke, M. V., Pang, T. P. S., Zajac, J. D., & MacLean, H. E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2010 · Cited by 78
Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function
Jayaraman, A., Lent-Schochet, D., & Pike, C. J. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0162-y · Cited by 81
Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome
Jones, T. H. (2007) · European Urology Supplements · doi:10.1016/j.eursup.2007.07.002 · Cited by 76
Self-citationErythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male
Jones, S. D., Dukovac, T., Sangkum, P., Yafi, F. A., & Hellstrom, W. J. G. (2015) · Sexual Medicine Reviews · doi:10.1002/smrj.43 · Cited by 76
Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system
Jones, T. H., & Kelly, D. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_6_18 · Cited by 76
Self-citationBarbonetti, A., Caterina Vassallo, M. R., Cotugno, M., Felzani, G., Francavilla, S., & Francavilla, F. (2016) · The Journal of Spinal Cord Medicine · doi:10.1179/2045772314y.0000000288 · Cited by 75
Metabolic and cardiovascular effects of androgen deprivation therapy
Hakimian, P., Blute, M., Kashanian, J. A., Chan, S. M., Silver, D. A., & Shabsigh, R. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07933.x · Cited by 74
Collier, A., Ghosh, S. K., McGlynn, B., & Hollins, G. W. (2011) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318201a406 · Cited by 73
Testosterone and Erectile Dysfunction
Yassin, A. A., & Saad, F. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.004630 · Cited by 73
Treatment of Hypogonadism with Testosterone in Patients with Type 2 Diabetes Mellitus
Gopal, R. A., Bothra, N., Acharya, S. V., Ganesh, H. K., Bandgar, T., Menon, P. S., & Shah, N. S. (2010) · Endocrine Practice · doi:10.4158/ep09355.or · Cited by 72
Consensus statement on diagnosis and clinical management of Klinefelter syndrome
Radicioni, A. F., Ferlin, A., Balercia, G., Pasquali, D., Vignozzi, L., Maggi, M., Foresta, C., & Lenzi, A. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03350351 · Cited by 72
Testosterone metabolites differentially regulate obesogenesis and fat distribution
Sebo, Z. L., & Rodeheffer, M. S. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101141 · Cited by 71
Erectile Dysfunction and Testosterone Deficiency
Blute, M., Hakimian, P., Kashanian, J. A., Shteynshluyger, A., Lee, M., & Shabsigh, R. (2008) · Frontiers of hormone research · doi:10.1159/000176048 · Cited by 71
Pastuszak, A. W., Gomez, L. P., Scovell, J. M., Khera, M., Lamb, D. J., & Lipshultz, L. I. (2015) · Sexual Medicine · doi:10.1002/sm2.76 · Cited by 71
Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men
Sarkar, M. A., Yates, K. P., Suzuki, A., Lavine, J. E., Gill, R. M., Ziegler, T. E., Terrault, N. A., & Dhindsa, S. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.053 · Cited by 71
Carson, C. C., & Rosano, G. M. C. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02337.x · Cited by 70
Corona, G., Rastrelli, G., Balercia, G., Lotti, F., Sforza, A., Monami, M., Forti, G., Mannucci, E., & Maggi, M. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02717.x · Cited by 69
Metabolic Syndrome and Sexual (Dys)function
Borges, R., Temido, P., Sousa, L., Azinhais, P., Conceição, P., Pereira, B. J., Leao, R. R. N., Retroz, E., Brandão, Á., Cristo, L., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01412.x · Cited by 66
Testosterone and metabolic syndrome
Cunningham, G. R. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.148068 · Cited by 65
Bhattacharya, R. K., Khera, M., Blick, G., Kushner, H., Nguyen, D., & Miner, M. M. (2011) · BMC Endocrine Disorders · doi:10.1186/1472-6823-11-18 · Cited by 63
Magnussen, L. V., Glintborg, D., Hermann, A. P., HOUGAARD, D. M., Højlund, K., & Andersen, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12701 · Cited by 64
Association between osteocalcin and glucose metabolism: a meta-analysis
Liu, D.-M., Guo, X., Tong, H.-J., Tao, B., Sun, L.-H., Zhao, H.-Y., Ning, G., & Liu, J. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3197-8 · Cited by 63
Rubinstein, A. L., Carpenter, D. M., & Minkoff, J. R. (2013) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31827c7b5d · Cited by 63
Metadata
- Authors
- Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H.
- Affiliations
- Barnsley Hospital NHS Foundation Trust (GB)
- National Health Service (GB)
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06
- Volume
- 154
- Issue
- 6
- Pages
- 899-906
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2142908894
- Cited by
- 791
- References
- 45
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 13 · 2023: 23 · 2022: 27 · 2021: 34 · 2020: 27 · 2019: 32 · 2018: 38 · 2017: 39 · 2016: 38 · 2015: 55 · 2014: 61 · 2013: 55 · 2012: 43
- FWCI
- 36.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- testosterone replacement therapy, hypogonadism, type 2 diabetes, insulin resistance, glycemic control, visceral fat, hypercholesterolemia, dyslipidemia, HbA1c, waist circumference, cardiovascular risk
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Type 2, Double-Blind Method, Humans, Hypercholesterolemia, Hypogonadism, Insulin Resistance, Male, Middle Aged, Testosterone, Cross-Over Studies, Hormone Replacement Therapy, Abdominal Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
